News

The Clinical and Translational Science Institute (CTSI) offers Spark Awards, previously known as vouchers, to researchers who need to jump-start their research. The goal of the Spark Award is to support preliminary work and generate essential data for both new and ongoing projects. The CTSI is proud to highlight how Spark Award recipients are utilizing their funding.

As the landscape of federal data availability continues to evolve, we recognize the need for investigators and teams to have access to alternative sources of information and data.

The Clinical and Translational Science Institute (CTSI) offers Spark Awards, previously known as vouchers, to researchers who need to jump-start their research. The goal of the Spark Award is to support preliminary work and generate essential data for both new and ongoing projects. The CTSI is excited to highlight how Spark Award recipients are utilizing their funding.

Julie Johnson, PharmD, director of The Ohio State University Clinical and Translational Science Institute (CTSI) has been selected to join a group of government, academia and industry stakeholders working together to identify critical issues in, and inspire action toward improving, the system of drug discovery, development and translation.

The Microbiome Informatics Webinar Series kicks off Tuesday, February 25, 2025, with Dr. Tom Delmont, a leading expert in microbial ecology and metagenomics. He will be diving into Anvi'o, a powerful open-source platform for microbiome data visualization and analysis.

We are pleased to announce that Dr. Amy Margolis has joined the Clinical and Translational Science Institute (CTSI) as the Co-Director of Workforce Development and Director of the Investigator Career Development and Training Program.

Liz Klein Ph.D, MPH, Ohio State CTSI leadership member, co-authored a recent study that found that quitline coaching significantly helped young adults who vape quit.

 This initiative provides training opportunities at both NCATS and FDA.

Due to the size and complexity of Ohio State’s portfolio of more than 7000 active IRB studies, the transition from Buck-IRB to Huron will occur in phases.